Chronic Liver Failure Clinical Trial
Official title:
To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
Study population: Patients admitted or seen in OPD (Out Patient Department), Department of
Hepatology.
Study design- Prospective Randomized Controlled Trial. Study period-January 2016 to May 2017
Intervention- Subjects will be randomized into 3 groups Group A subjects will receive ω3 PUFA
(Polyunsaturated Fatty Acids) (10% Omegavan 100 ml).
Group B- will receive ω6 PUFA (Polyunsaturated Fatty Acids) (10% Intralipid 100 ml).
Group C -Placebo group
Monitoring and assessment- :- The following tests will be done in these patients:-
1. Complete clinical examination.
2. Serum electrolytes- sodium, potassium, calcium, magnesium, phosphate levels
3. BUN (Blood Urea Nitrogen)
4. Serum free fatty acid levels
5. Lipid profile.
6. Arterial ammonia
7. Arterial lactate
8. Blood sugar and serum insulin levels
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04546048 -
The Early Strength Training Program in Post-transplant Liver Cases
|
N/A | |
| Recruiting |
NCT05107271 -
Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
|
||
| Completed |
NCT04143230 -
Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool
|
N/A | |
| Not yet recruiting |
NCT05727722 -
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
|
Phase 1 | |
| Completed |
NCT06240832 -
Aerobic Capacity Muscle Strength and Health Related Quality of Life in Children With Chronic Liver Disease
|
N/A | |
| Completed |
NCT01872767 -
Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure
|
N/A | |
| Recruiting |
NCT04335058 -
Lactoferrin in Treatment of Fe Deficient Anemia In Cirrhosis
|
N/A |